(Q44906174)

7 December 2017

title

Cannabis use and cognitive functions in at-risk mental state and first episode psychosis (English)

1 reference

7 December 2017

1 reference

6

1 reference

7 December 2017

Anita Riecher-Rössler

7

1 reference

7 December 2017

E Studerus

2

0 references

author name string

H Bugra

1

1 reference

7 December 2017

C Rapp

3

1 reference

7 December 2017

C Tamagni

4

1 reference

7 December 2017

J Aston

5

1 reference

7 December 2017

publication date

12 June 2013

1 reference

7 December 2017

1 reference

7 December 2017

volume

230

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

299-308

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-013-3157-y

7 December 2017

exact match

0 references

cites work

Self-report of cognitive abilities in temporal lobe epilepsy: cognitive, psychosocial, and emotional factors.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Neural substrates of faulty decision-making in abstinent marijuana users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Cognitive functioning in prodromal psychosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

How Many Imputations are Really Needed? Some Practical Clarifications of Multiple Imputation Theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Cannabis use and cognition in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Persistent cannabis users show neuropsychological decline from childhood to midlife

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

What do we know about neuropsychological aspects of schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Neuropsychological deficits in individuals with an at risk mental state for psychosis - working memory as a potential trait marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Cannabis use and cognitive functioning in first-episode schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Neurological soft signs in patients with psychosis and cannabis abuse: a systematic review and meta-analysis of paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

The dual neuroprotective-neurotoxic profile of cannabinoid drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

The role of cannabis in cognitive functioning of patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Neurocognitive functioning and cannabis use in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Cannabis use in patients at clinical high risk of psychosis: impact on prodromal symptoms and transition to psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

The Basel early-detection-of-psychosis (FEPSY)-study ? design and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Das Basel Screening Instrument für Psychosen (BSIP): Entwicklung, Aufbau, Reliabilität und Validität

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3157-Y

Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis

21 January 2018

1 reference

12 December 2020

[Cognitive abnormalities and cannabis use].

1 reference

12 December 2020

Cannabinoids for the treatment of schizophrenia? A balanced neurochemical framework for both adverse and therapeutic effects of cannabis use.

1 reference

12 December 2020

Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

1 reference

12 December 2020

The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations

1 reference

12 December 2020

Prediction of psychosis. A step towards indicated prevention of schizophrenia.

1 reference

12 December 2020

A continuous performance test of brain damage.

1 reference

12 December 2020

PACE: a specialised service for young people at risk of psychotic disorders.

1 reference

12 December 2020

10.1007/S00213-013-3157-Y

Identifiers

DOI

1 reference

7 December 2017

1 reference